Showing results (1-10 of 273) with videos related to
Sort By:
Pageof 28
Trends in Molecular Medicine|November 24, 2021
Linking liver metabolic and vascular disease via bile acid signalingStefano Fiorucci, Eleonora DistruttiHandbook of Experimental Pharmacology|June 16, 2019
The Pharmacology of Bile Acids and Their ReceptorsStefano Fiorucci, Eleonora DistruttiTrends in Molecular Medicine|October 21, 2015
Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic DisordersStefano Fiorucci, Eleonora DistruttiHandbook of Experimental Pharmacology|July 4, 2019
Chenodeoxycholic Acid: An Update on Its Therapeutic ApplicationsStefano Fiorucci, Eleonora DistruttiPharmacological Research|August 1, 2016
Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertensionStefano Fiorucci, Eleonora DistruttiCurrent Topics in Medicinal Chemistry|January 17, 2012
Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disordersStefano Fiorucci, Angela Zampella, Eleonora DistruttiPharmacological Research|July 19, 2018
Future trends in the treatment of non-alcoholic steatohepatitisStefano Fiorucci, Michele Biagioli, Eleonora DistruttiHandbook of Experimental Pharmacology|June 16, 2019
Obeticholic Acid: An Update of Its Pharmacological Activities in Liver DisordersStefano Fiorucci, Cristina Di Giorgio, Eleonora DistruttiFrontiers in Immunology|August 29, 2018
Bile Acids Activated Receptors Regulate Innate ImmunityStefano Fiorucci, Michele Biagioli, Angela Zampella, et al.Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver DisordersStefano Fiorucci, Ginevra Urbani, Eleonora Distrutti, et al.Pageof 28